Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

249.07
Delayed Data
As of 4:03pm ET
 +2.66 / +1.08%
Today’s Change
184.50
Today|||52-Week Range
261.27
+18.60%
Year-to-Date
State of Play
1:59pm / TheStreet.com - Paid Partner Content
Jarislowsky, Fraser Ltd Buys CGI Group Inc, Berkshire Hathaway Inc, Nielsen Holdings ...
Jul 18 / GuruFocus News - Paid Partner Content
Oakbrook Investments Llc Buys Schlumberger, JPMorgan Chase, Visa Inc, Sells W.W. ...
9:39am / GuruFocus News - Paid Partner Content
Paratek Antibiotic Candidate's Phase III Data Favorable
Jul 18 / Zacks.com - Paid Partner Content
The World's Largest Generic Drugmaker Is Plunging
Jul 19 / GuruFocus News - Paid Partner Content
Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod
Jul 17 / Zacks.com - Paid Partner Content
Equitec Specialists, Llc Buys Dominion Energy Inc, Arconic Inc, Welltower Inc, Sells ...
Jul 19 / GuruFocus News - Paid Partner Content
3 Biotechs to Buy This Summer
Jul 14 / TheStreet.com - Paid Partner Content
Sit Investment Associates Inc Buys Allergan PLC, Oracle Corp, ClearBridge Energy MLP ...
Jul 19 / GuruFocus News - Paid Partner Content
Alder BioPharmaceuticals: Cramer's Top Takeaways
Jul 13 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close246.41
Today’s open247.42
Day’s range247.09 - 251.63
Volume2,412,874
Average volume (3 months)2,240,058
Market cap$82.8B
Dividend yield1.12%
Data as of 4:03pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.01%
Earnings growth (next 5 years)+14.85%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.16

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.98+2.30%
AZNAstraZeneca+0.29+0.86%
ABTAbbott Laboratories+1.42+2.87%
BMYBristol-Myers Squibb+0.37+0.67%
Data as of 4:03pm ET, 07/20/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$3.93
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts